- Home
- LIPO vs NVVE Comparison
LIPO vs NVVE Comparison
Compare LIPO & NVVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIPO
- NVVE
- Stock Information
- Founded
- LIPO 2005
- NVVE 1996
- Country
- LIPO United States
- NVVE United States
- Employees
- LIPO N/A
- NVVE N/A
- Industry
- LIPO Biotechnology: Pharmaceutical Preparations
- NVVE Oil Refining/Marketing
- Sector
- LIPO Health Care
- NVVE Energy
- Exchange
- LIPO Nasdaq
- NVVE Nasdaq
- Market Cap
- LIPO 3.1M
- NVVE 3.7M
- IPO Year
- LIPO 2022
- NVVE N/A
- Fundamental
- Price
- LIPO $2.57
- NVVE $1.10
- Analyst Decision
- LIPO Strong Buy
- NVVE
- Analyst Count
- LIPO 1
- NVVE 0
- Target Price
- LIPO $16.00
- NVVE N/A
- AVG Volume (30 Days)
- LIPO 45.5K
- NVVE 215.5K
- Earning Date
- LIPO 05-08-2025
- NVVE 03-31-2025
- Dividend Yield
- LIPO N/A
- NVVE N/A
- EPS Growth
- LIPO N/A
- NVVE N/A
- EPS
- LIPO N/A
- NVVE N/A
- Revenue
- LIPO $536,357.00
- NVVE $5,286,229.00
- Revenue This Year
- LIPO N/A
- NVVE $200.61
- Revenue Next Year
- LIPO N/A
- NVVE $109.43
- P/E Ratio
- LIPO N/A
- NVVE N/A
- Revenue Growth
- LIPO 19.29
- NVVE N/A
- 52 Week Low
- LIPO $2.02
- NVVE $1.00
- 52 Week High
- LIPO $12.00
- NVVE $17.30
- Technical
- Relative Strength Index (RSI)
- LIPO 48.43
- NVVE 26.96
- Support Level
- LIPO $2.13
- NVVE $1.53
- Resistance Level
- LIPO $2.74
- NVVE $1.75
- Average True Range (ATR)
- LIPO 0.21
- NVVE 0.15
- MACD
- LIPO 0.05
- NVVE 0.02
- Stochastic Oscillator
- LIPO 76.06
- NVVE 13.33
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.